53 related articles for article (PubMed ID: 8184989)
1. Human brain receptors,V. Binding and message.
Meador-Woodruff JH; Watson SJ; Tamminga CA
Am J Psychiatry; 1994 Jun; 151(6):804. PubMed ID: 8184989
[No Abstract] [Full Text] [Related]
2. Quantitation of neuroreceptors: a need to increase imaging resolution?
Kuikka JT
J Nucl Med; 1996 Nov; 37(11):1911-2. PubMed ID: 8917202
[No Abstract] [Full Text] [Related]
3. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
[TBL] [Abstract][Full Text] [Related]
4. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
[No Abstract] [Full Text] [Related]
5. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.
Rinne UK; Laihinen A; Rinne JO; Någren K; Bergman J; Ruotsalainen U
Mov Disord; 1990; 5(1):55-9. PubMed ID: 2136932
[TBL] [Abstract][Full Text] [Related]
6. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
Noguchi-kuno SA; Nakata C; Nishitani H
Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
[No Abstract] [Full Text] [Related]
7. Dopamine receptor mRNA expression in human striatum and neocortex.
Meador-Woodruff JH; Damask SP; Wang J; Haroutunian V; Davis KL; Watson SJ
Neuropsychopharmacology; 1996 Jul; 15(1):17-29. PubMed ID: 8797188
[TBL] [Abstract][Full Text] [Related]
8. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.
Rinne JO; Laihinen A; Någren K; Bergman J; Solin O; Haaparanta M; Ruotsalainen U; Rinne UK
J Neurosci Res; 1990 Dec; 27(4):494-9. PubMed ID: 1981915
[TBL] [Abstract][Full Text] [Related]
9. Effects of cocaine on D3 and D4 receptor expression in the human striatum.
Meador-Woodruff JH; Little KY; Damask SP; Watson SJ
Biol Psychiatry; 1995 Aug; 38(4):263-6. PubMed ID: 8547449
[No Abstract] [Full Text] [Related]
10. Imaging dopamine receptors in the rat striatum with the MicroPET R4: kinetic analysis of [11C]raclopride binding using graphical methods.
Alexoff DL; Vaska P; Logan J
Methods Enzymol; 2004; 385():213-28. PubMed ID: 15130741
[No Abstract] [Full Text] [Related]
11. Measurement of D2 dopamine receptor-specific carbon-11-YM-09151-2 binding in the canine brain by PET: importance of partial volume correction.
Hatazawa J; Hatano K; Ishiwata K; Itoh M; Ido T; Kawashima K; Meguro K; Watanuki S; Seo S
J Nucl Med; 1991 Apr; 32(4):713-8. PubMed ID: 1672888
[TBL] [Abstract][Full Text] [Related]
12. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
Kung MP; Kung HF; Billings J; Yang Y; Murphy RA; Alavi A
J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
[TBL] [Abstract][Full Text] [Related]
13. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
Baron JC; Mazière B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet AM; Agid Y
J Cereb Blood Flow Metab; 1986 Apr; 6(2):131-6. PubMed ID: 3485639
[TBL] [Abstract][Full Text] [Related]
14. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K
Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732
[No Abstract] [Full Text] [Related]
15. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
Seeman P; Guan HC; Niznik HB
Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
[No Abstract] [Full Text] [Related]
16. High-affinity dopamine receptors solubilized from dog striatum [proceedings].
Gorissen H; Laduron P
Arch Int Physiol Biochim; 1979 May; 87(2):414-5. PubMed ID: 92960
[No Abstract] [Full Text] [Related]
17. High affinity dopamine receptors (D3) in rat brain.
Titeler M; List S; Seeman P
Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
[No Abstract] [Full Text] [Related]
18. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
Valchár M; Dobrovský K; Krejcí I; Dlabac A
Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
[No Abstract] [Full Text] [Related]
19. Analysis of gene expression in striatal tissue by multiprobe RNase protection assay.
Richtand NM
Methods Mol Med; 2003; 79():181-92. PubMed ID: 12506697
[No Abstract] [Full Text] [Related]
20. Melatonin binding to D2 receptors in rat striatum: a comparative study with calmodulin antagonists.
Chávez JL; Antón-Tay F; Benítez-King G
Proc West Pharmacol Soc; 1991; 34():413-6. PubMed ID: 1838608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
